A recent study offering a comprehensive view of the genome and transcriptome of gastrointestinal stromal tumors (GISTs) has introduced a new, multi-omics-based molecular classification of these tumors ...

GISTs originate from interstitial cells of Cajal and are staged by size, location, mitotic rate, and genetic mutations, influencing treatment strategies. Diagnosis involves imaging, endoscopy, biopsy, ...

Early stage GIST may be curable, but there is a risk of recurrence. The overall relative 5-year survival rate for GIST is 83 percent, but this varies by stage and other factors. Newer therapies offer ...

Colonic schwannomas are rare, generally benign tumours that originate from Schwann cells in the neural sheath. They are often identified incidentally as submucosal masses during routine colonoscopy ...

GIST is an acronym that stands for gastrointestinal stromal tumor. This type of cancer starts in interstitial cells of Cajal (ICCs), which are special cells that line the walls of the gastrointestinal ...

Gastrointestinal stromal tumors (GISTs) are growths that form in the digestive tract. The overall GIST survival rate for 5 years is 85%. However, this rate cannot predict the survival of any ...

Patients with GIST have more treatment options than ever, with others currently under development. On a summer Sunday in 2011, Lee Keenan competed in the Pleasant Prairie Triathlon in Wisconsin. At 42 ...